Literature DB >> 9400444

The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer.

G G Hermann1, T Horn, K Steven.   

Abstract

PURPOSE: We assessed the influence of the level of lamina propria invasion and the prevalence of p53 nuclear immunoreactivity on the survival of patients with stage T1 transitional cell bladder cancer.
MATERIALS AND METHODS: All patients presenting with stage T1 bladder cancer were prospectively and routinely grouped according to the level of lamina propria invasion. Invasion of the tumor stalk was defined as stage T1a, invasion of the lamina propria proper superficial to the level of muscularis mucosa as stage T1b and into or deeper than the muscularis mucosa as stage T1c. The p53 nuclear immunoreactivity was determined with antibody PAB 1801.
RESULTS: The study comprised 143 patients including 31 (22%) with stage T1a disease, 60 (42%) with stage T1b and 52 (36%) with stage T1c. Mean patient age was 67 years (range 38 to 92) and mean followup was 4.7 years (range 2.4 to 9.7). Tumor grade related to the depth of lamina propria invasion (p < 0.05) and the prevalence of dysplasia in random mucosal biopsies was higher in stage T1b and T1c tumors than in stage T1a. Of all tumors 42% expressed p53 nuclear reactivity which correlated with tumor grade (p < 0.05). Also the prevalence of nuclear p53 was higher in stages T1b and T1c compared with T1a disease. Of the patients 115 were treated with transurethral resection alone and 28 underwent radical cystectomy. Overall survival was 60.1%. Age was the only independent predictor of survival in patients older than 75 years. For patients up to 75 years old survival related to age, level of lamina propria invasion and presence of p53 nuclear accumulation. For this subpopulation overall survival was 67%, and 79% for stage T1a, 70% for stage T1b and 57% for stage T1c (p < 0.05). Survival was higher in patients with p53 negative (73%) than in those with p53 positive (61%) tumors (p < 0.05). A multivariate analysis of the influence of lamina propria invasion and nuclear p53 status on survival histology was found to be the only independent predictor of survival.
CONCLUSIONS: Immediate radical cystectomy should be considered for patients with stage T1c tumors and for some patients with stage T1b disease, particularly those with tumors expressing p53 nuclear reactivity and with dysplasia in the random mucosal biopsies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9400444     DOI: 10.1016/s0022-5347(01)64021-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

1.  False-positive lesions detected by fluorescence cystoscopy: any association with p53 and p16 expression?

Authors:  K Hendricksen; P M J Moonen; A G der Heijden; J A Witjes
Journal:  World J Urol       Date:  2006-09-22       Impact factor: 4.226

2.  Consistency of microstaging pT1 bladder transitional cell carcinoma.

Authors:  Lorna Cottrell; Edwin Robert Nairn; Mario Hair
Journal:  J Clin Pathol       Date:  2007-02-23       Impact factor: 3.411

Review 3.  [Urinary bladder tumours. The new 2004 WHO classification].

Authors:  M Seitz; D Zaak; R Knüchel-Clarke; C Stief
Journal:  Urologe A       Date:  2005-09       Impact factor: 0.639

4.  Human papilloma virus and p53 expression in bladder cancer in Egypt: relationship to schistosomiasis and clinicopathologic factors.

Authors:  Thanaa El A Helal; Mona T Fadel; Naglaa K El-Sayed
Journal:  Pathol Oncol Res       Date:  2006-09-23       Impact factor: 3.201

5.  Stalk versus base invasion in pT1 papillary cancers of the bladder: improved substaging system predicting the risk of progression.

Authors:  Margaret Lawless; Roman Gulati; Maria Tretiakova
Journal:  Histopathology       Date:  2017-06-27       Impact factor: 5.087

Review 6.  Molecular pathology of non-invasive urothelial carcinomas (part I).

Authors:  Burkhard Helpap; Bernd J Schmitz-Dräger; Peter W Hamilton; Giovanni Muzzonigro; Andrea B Galosi; Karl H Kurth; David Lubaroff; David J Waters; Michael J Droller
Journal:  Virchows Arch       Date:  2003-02-11       Impact factor: 4.064

7.  Prognostic role of substaging in T1G3 transitional cell carcinoma of the urinary bladder.

Authors:  Vincenzo DE Marco; Maria Angela Cerruto; Carolina D'Elia; Matteo Brunelli; Oscar Otte; Anila Minja; Claudio Luchini; Giovanni Novella; Stefano Cavalleri; Guido Martignoni; Walter Artibani
Journal:  Mol Clin Oncol       Date:  2014-05-08

8.  Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer.

Authors:  Jun Ruan; Bingbing Wei; Zhuoqun Xu; Shudong Yang; You Zhou; Minhong Yu; Jiabei Liang; Ke Jin; Xing Huang; Peng Lu; Huan Cheng
Journal:  Med Oncol       Date:  2013-01-10       Impact factor: 3.064

9.  Completeness of bladder cancer staging in the Danish Cancer Registry, 2004-2009.

Authors:  Louise Holland-Bill; Trine Frøslev; Søren Friis; Morten Olsen; Niels Harving; Michael Borre; Mette Søgaard
Journal:  Clin Epidemiol       Date:  2012-08-17       Impact factor: 4.790

10.  Bladder cancer: a simple model becomes complex.

Authors:  Giovanni Battista Di Pierro; Caterina Gulia; Cristiano Cristini; Giorgio Fraietta; Lorenzo Marini; Pietro Grande; Vincenzo Gentile; Roberto Piergentili
Journal:  Curr Genomics       Date:  2012-08       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.